Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone

被引:83
|
作者
Enomoto, N [1 ]
Takei, Y [1 ]
Hirose, M [1 ]
Konno, A [1 ]
Shibuya, T [1 ]
Matsuyama, S [1 ]
Suzuki, S [1 ]
Ikejima, K [1 ]
Kitamura, T [1 ]
Sato, N [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
D O I
10.1124/jpet.102.047217
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonists of peroxisome proliferator-activated receptor (PPAR)-gamma have been shown to reduce tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance. On the other hand, sensitization of Kupffer cells to lipopolysaccharide (LPS) and their production of TNF-alpha are critical for progression of alcoholic liver injury. This study was intended to determine whether pioglitazone, a PPAR-gamma agonist, could prevent alcohol-induced liver injury. Rats were given ethanol (5 g/kg b.wt.) and pioglitazone (500 mug/kg) once every 24 h intragastrically. Ethanol for 8 weeks caused pronounced steatosis, necrosis, and inflammation in the liver. These pathological parameters were diminished greatly by pioglitazone. Kupffer cells were sensitized to LPS after ethanol for 4 weeks as evidenced by aggravation of liver pathology induced by LPS (5 mg/kg) and enhancement of LPS (100 ng/ml)-induced intracellular Ca2+ concentration elevation in Kupffer cells. The parameters were diminished by treatment with pioglitazone. LPS-induced TNF-alpha production by Kupffer cells from the 4-week ethanol group was 3 to 4 times higher than control. This increase was blunted by 70% with pioglitazone. Gut permeability was 10-fold higher in the 4-week ethanol group, and pioglitazone treatment did not change the value. Inclusion of TNF-alpha in culture media of Kupffer cells enhanced CD14 expression, LPS-induced intracellular Ca2+ concentration response, and production of TNF-alpha. These results indicate that pioglitazone prevents alcoholic liver injury through abrogation of Kupffer cell sensitization to LPS.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 50 条
  • [31] Fenofibrate, a peroxisome proliferator-activated receptor-α agonist, exerts anticonvulsive properties
    Porta, Natacha
    Vallee, Louis
    Lecointe, Cecile
    Bouchaert, Emmanuel
    Staels, Bart
    Bordet, Regis
    Auvin, Stephane
    EPILEPSIA, 2009, 50 (04) : 943 - 948
  • [32] Peroxisome Proliferator-Activated Receptor-δ as Emerging Target in Liver Disease
    Schnabl, Bernd
    DRUG DEVELOPMENT RESEARCH, 2010, 71 (02) : 106 - 111
  • [33] Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis
    Suzuki, Shugo
    Mori, Yukiko
    Nagano, Aya
    Naiki-Ito, Aya
    Kato, Hiroyuki
    Nagayasu, Yuko
    Kobayashi, Mizuho
    Kuno, Toshiya
    Takahashi, Satoru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12):
  • [34] Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for the Treatment or Prevention of Alcoholic Liver Disease
    Koga, Takayuki
    Peters, Jeffrey M.
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (11) : 1598 - 1606
  • [35] Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates acrolein-induced airway mucus hypersecretion in rats
    Liu, Dai-Shun
    Liu, Wei-Jia
    Chen, Lei
    Ou, Xue-Mei
    Wang, Tao
    Feng, Yu-Lin
    Zhang, Shang-Fu
    Xu, Dan
    Chen, Ya-Juan
    Wen, Fu-Qiang
    TOXICOLOGY, 2009, 260 (1-3) : 112 - 119
  • [36] Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
    Luo, YM
    Yin, W
    Signore, AP
    Zhang, F
    Hong, Z
    Wang, SP
    Graham, SH
    Chen, J
    JOURNAL OF NEUROCHEMISTRY, 2006, 97 (02) : 435 - 448
  • [37] Peroxisome proliferator-activated receptor-γagonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model
    Corsini, Iuri
    Polvani, Simone
    Tarocchi, Mirko
    Tempesti, Sara
    Marroncini, Giada
    Generoso, Marta
    Bresci, Cecilia
    Gozzini, Elena
    Bianconi, Tommaso
    Galli, Andrea
    Dani, Carlo
    PEDIATRIC RESEARCH, 2017, 81 (02) : 364 - 368
  • [38] Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-γ agonist:: Molecular mechanism of the antiproteinuric effect of pioglitazone
    Benigni, Ariela
    Zoja, Carla
    Tomasoni, Susanna
    Campana, Marco
    Corna, Daniela
    Zanchi, Cristina
    Gagliardini, Elena
    Garofano, Elvira
    Rottoli, Daniela
    Ito, Takahito
    Remuzzi, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (06): : 1624 - 1632
  • [39] Peroxisome proliferator-activated receptor-γ agonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model
    Iuri Corsini
    Simone Polvani
    Mirko Tarocchi
    Sara Tempesti
    Giada Marroncini
    Marta Generoso
    Cecilia Bresci
    Elena Gozzini
    Tommaso Bianconi
    Andrea Galli
    Carlo Dani
    Pediatric Research, 2017, 81 : 364 - 368
  • [40] Effect of peroxisome proliferator-activated receptor-α agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats
    Pathak, Rahul
    Asad, Mohammed
    Hrishikeshavan, H. Jagannath
    Prasad, Satya
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 (03) : 291 - 296